Idexx Laboratories (IDXX) EBT Margin (2009 - 2026)

Idexx Laboratories has reported EBT Margin for 18 years, with the latest figure at 34.29% in Q2 2026.

• On a quarterly basis, EBT Margin rose 163.0% year-over-year to 34.29% in Q2 2026; TTM through Jun 2026 was 31.28%, a 88.0% increase from a year earlier, with the FY2025 full-year figure at 30.77%, up 229.0% from the prior year.
• EBT Margin was 34.29% for Q2 2026 at Idexx Laboratories, up from 31.16% in the prior quarter.
• The five-year high for EBT Margin was 34.29% in Q2 2026, with the low at 19.88% in Q2 2022.
• Average EBT Margin over 5 years is 28.93%, with a median of 29.5% recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EBT Margin plunged 1059 bps in 2022, then jumped 1042 bps in 2023.
• Over 5 years, EBT Margin stood at 25.73% in 2022, then increased by 3 bps to 26.58% in 2023, then advanced by 1 bps to 26.87% in 2024, then advanced by 5 bps to 28.15% in 2025, then rose by 22 bps to 34.29% in 2026.
• The last three EBT Margin figures came in at 34.29% (Q2 2026), 31.16% (Q1 2026), and 28.15% (Q4 2025), per Business Quant data.